Ahead of adcomm, FDA flags 'systemic bias' in Amgen's late-stage Lumakras trial
3rd October 2023 Uncategorised 0Ahead of adcomm, FDA flags ‘systemic bias’ in Amgen’s late-stage Lumakras trial zbecker Tue, 10/03/2023 – 13:41 More: Ahead of adcomm, FDA flags 'systemic bias' in Amgen's late-stage Lumakras trial Source: fierce
read more